Cancers Treated With Combination of Antrodia Cinnamomea and Chemotherapy

Inclusion Criteria:

* Histologically or cytologically confirmed Cancer.
* Age ≦ 80 years old and ≧ 18 years old.
* Eastern Cooperative Oncology Group(ECOG) performance status of 0-2.
* Adequate organ function, including followings Hepatic： Total bilirubin level ≦1.5 x UNL, GOT and GPT ≦ 2.5 x UNL if no liver metastasis; GOT and GPT ≦ 5 x UNL if liver metastasis. Renal： Creatinine level\< 1.5 milligram per deciliter or Estimated creatinine clearance(CCr) ≧ 60 milliliter per minute (CCr is estimated by Cockcroft-Gault formula, as appendix II)
* Estimated life expectancy of at least 12 weeks.
* Written(signed) Informed Consent
* Ever treated and poor tolerance with platinum-based or anthracycline- based regimen, likely nausea and vomiting.

Exclusion Criteria:

* Prior participation in any investigational drug study within 28 days
* Active uncontrolled infections or human immunodeficiency virus(HIV) infection
* Significant concurrent medical diseases, such as congestive heart failure, unstable angina, acute or recent myocardial infarction( 6 months before randomization), chronic obstructive pulmonary disease with frequent exacerbation, chronic renal diseases (estimated CCr 60 milliliter per minute), uncontrolled diabetes, uncontrolled hypertension, recent cerebrovascular disease episode( 6 months before randomization )
* With clinically significant Gastrointestinal disorder (e.g. bleeding, inflammation, obstruction or diarrhea)
* Psychiatric disorders that would compromise the patient's compliance or decision.
* Pregnancy or breast feeding.
* Known hypersensitivity to the component of investigational drugs.
* Known or suspected Gilbert's syndrome
* Poor compliance